Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: Prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy

The malignant pleural mesothelioma (MPM) response rate to chemotherapy is low. The identification of imaging biomarkers that could help guide the most effective therapy approach for individual patients is highly desirable.